1. Home
  2. companies
  3. overactive bladder

overactive bladder

Teva Pharma Detrol Launches Sales of Generic Detrol
Teva Pharma Detrol Launches Sales of Generic Detrol
Daily Finance
generics
Teva
Detrol LA
overactive bladder
FDA OKs over-the-counter version of Merck overactive bladder drug
FDA OKs over-the-counter version of Merck overactive bladder drug
Reuters
FDA
Merck
overactive bladder
Oxytrol
Allergan's Botox Label Expanded
Allergan's Botox Label Expanded
Yahoo/Zacks
Allergan
Botox
overactive bladder
Mylan Inc arm gets US OK for Tolterodine tartrate tablets
Mylan Inc arm gets US OK for Tolterodine tartrate tablets
Healthcare Global
Mylan
generics
Detrol
overactive bladder
Merck May Not Have Shown Women Can Safely Choose Drug
Merck May Not Have Shown Women Can Safely Choose Drug
Bloomberg
Merck
Oxytrol
overactive bladder
Astellas launches bladder drug, aiming for a $1.9B franchise
Astellas launches bladder drug, aiming for a $1.9B franchise
Fierce Pharma
Astellas
Myrbetriq
overactive bladder
Allergan’s Botox Shot Helps Overactive Bladder in Women
Allergan’s Botox Shot Helps Overactive Bladder in Women
Bloomberg
Botox
Allergan
overactive bladder
Pfizer
Pfizer
Yahoo/Investor's Business Daily
Pfizer
Mylan
Detrol
overactive bladder
Mylan will launch generic Detrol LA in 2014
Mylan will launch generic Detrol LA in 2014
Yahoo/AP
Detrol LA
generics
Mylan
Pfizer
overactive bladder
Astellas Bladder Treatment Wins U.S. Approval For Sale
Astellas Bladder Treatment Wins U.S. Approval For Sale
Bloomberg
Astellas
FDA
overactive bladder
mirabegron
Watson Pharma says federal appeals court agrees 4 Sanctura XR patents are not valid
Watson Pharma says federal appeals court agrees 4 Sanctura XR patents are not valid
Yahoo/AP
Watson
Sanctura XR
patents
overactive bladder
Watson, Antares launch Gelnique 3% for overactive bladder treatment
Watson, Antares launch Gelnique 3% for overactive bladder treatment
Pharmabiz
Watson Pharmaceuticals
Antares Pharma
Gelnique
overactive bladder
Astellas Wins FDA Panel Backing for Overactive Bladder Drug
Astellas Wins FDA Panel Backing for Overactive Bladder Drug
Bloomberg
FDA
overactive bladder
Astellas
mirabegron
Astellas Overactive Bladder Drug Raises Risks, FDA Staff Says
Astellas Overactive Bladder Drug Raises Risks, FDA Staff Says
Bloomberg
Astellas
overactive bladder
FDA
mirabegron
Allergan Botox works in overactive bladder studies
Allergan Botox works in overactive bladder studies
Reuters
Botox
Allergan
overactive bladder
Pfizer, Social Media & Clinical Trials: Lipset Explains
Pfizer, Social Media & Clinical Trials: Lipset Explains
Pharmalot
Pfizer
social media
clinical trials
overactive bladder
Detrol
US FDA approves Antares' oxybutynin gel for overactive bladder treatment
US FDA approves Antares' oxybutynin gel for overactive bladder treatment
Pharmabiz
Antares Pharma
oxybutynin gel
overactive bladder
FDA, EMA accept Astellas bladder drug for review
FDA, EMA accept Astellas bladder drug for review
Pharma Times, UK
FDA
EMA
overactive bladder
Astellas
mirabegron
Multitalented Botox could get $500M off bladder indication
Multitalented Botox could get $500M off bladder indication
Fierce Pharma
Botox
Allergan
overactive bladder
Pfizer starts first US "virtual" clinical study, under pilot FDA program using Internet
Pfizer starts first US "virtual" clinical study, under pilot FDA program using Internet
Yahoo/AP
clinical studies
Pfizer
FDA
Detrol
overactive bladder

Click here to subscribe to daily news headlines in your email inbox